AnalytiCon Discovery is a German R&D company specializing in natural product research for the pharma, cosmetic, and food industries. They provide substance libraries, active ingredient identification, synthesis, and production services.
AnalytiCon Discovery is a research and development company specializing in natural product chemistry and small molecule compounds. Based in Potsdam, Germany, the company provides end-to-end services for the pharmaceutical, cosmetic, food, and agricultural sectors. Their capabilities span the entire discovery value chain, including the establishment of proprietary substance libraries, identification of active ingredients, synthetic optimization, and commercial-scale production. The company leverages an integrated approach that combines microbiology, natural product isolation, state-of-the-art analytical technologies like NMR and LC/MS, and advanced screening platforms. Since 2013, AnalytiCon has operated as a member of the BRAIN Biotech Group, utilizing specialized laboratories and a team of experts to transform natural molecules into viable, innovative products.
By offering deep expertise in natural product-based discovery, AnalytiCon serves as a critical partner for organizations seeking to overcome the complexities of medicinal chemistry and substance development. They solve significant industry challenges by providing high-quality, fully elucidated compound collections that expedite preclinical discovery projects and research into novel therapeutic targets. Their track record includes numerous successful collaborations with global pharmaceutical and consumer goods companies, focusing on applications such as drug discovery, sugar and calorie reduction, and natural preservation ingredients. Through their combination of technical competence and solution-oriented project management, they enable partners to accelerate the development of sustainable, bio-based products for diverse global markets.